Martin Shkreli's Biotech Short Position Is Blowing Up As Stock Soars 440%: Momentum Score Spikes - Capricor Therapeutics (NASDAQ:CAPR)

Investor Martin Shkreli’s big biotech short position is blowing up after the stock’s monumental rally over the past week, following a major clinical catalyst. Popularly known as “Pharma bro,” Shkreli initiated a short position against California-based Capricor Therapeutics Inc. (NASDAQ: CAPR) two weeks ago, referring to the company’s HOPE-3 cell therapy for Duchenne Muscular Dystrophy as “COPE-3.”“It will not work. This is the company's only asset,” Shkreli said, yet the company cleared a major regulatory h ...